Transfection Reagents

Introduction to Transfection Reagents

Transfection is a widely used molecular biology technique for introducing nucleic acids—such as siRNA, miRNA, or plasmid DNA—into eukaryotic cells. In RNA-based applications, particularly those involving RNA interference (RNAi), the goal is to deliver siRNA molecules into the cytoplasm where they can engage the RNA-induced silencing complex (RISC) and mediate sequence-specific degradation of target mRNA. The effectiveness of this process depends heavily on the choice of transfection reagent and method, both of which influence delivery efficiency, gene knockdown specificity, and cell viability.

Importance of Optimized RNA Delivery

Successful siRNA transfection requires careful optimization of several variables, including reagent formulation, siRNA stability, cell line characteristics, and culture conditions. Transfection reagents are typically designed to facilitate cellular uptake while minimizing cytotoxicity and off-target effects. In particular, serum compatibility, RNase-free composition, and intracellular release kinetics are critical factors that determine the success of siRNA delivery. Depending on the delivery method—lipid-based or electroporation—distinct reagent formulations are necessary to maintain membrane integrity, support rapid intracellular recovery, and achieve high transfection efficiency.

Role of Functional and Negative Controls

Well-designed RNAi experiments rely on appropriate controls to ensure specificity and reproducibility. Functional siRNA controls, such as those that induce apoptosis or cell cycle arrest, are used to validate transfection conditions and confirm downstream cellular responses. These reagents silence genes involved in mitochondrial stability or cell cycle progression, resulting in measurable phenotypes such as caspase activation or phase-specific cell accumulation. On the other hand, non-silencing control siRNA serves as a negative control. It mimics the physical and chemical properties of active siRNA without targeting any known gene, allowing researchers to distinguish true gene-specific effects from non-specific cellular responses.

Electroporation and Buffer Considerations

For cell types that are difficult to transfect using chemical methods, electroporation provides a highly effective alternative. This technique uses short electrical pulses to transiently permeabilize the plasma membrane, enabling siRNA molecules to enter the cytoplasm directly. The composition of the electroporation buffer plays a key role in determining efficiency and viability. Buffers with low conductivity, physiological osmolarity, and membrane-stabilizing agents help prevent cellular damage, reduce thermal effects, and promote resealing of the membrane post-pulse. Optimized buffers are essential for maintaining cell health while achieving high levels of siRNA uptake, particularly in primary or suspension cells.

Overview of Available Reagent Types

This page features several types of transfection-related reagents commonly used in RNAi research. These include siRNAs that induce cell cycle arrest or apoptosis for use as functional benchmarks; non-silencing control siRNAs to validate specificity; and electroporation buffers formulated to enhance RNA delivery while preserving cell viability. Each reagent serves a unique purpose in supporting experimental consistency, reproducibility, and biological relevance.

Apoptosis Inducing siRNA

Mechanism of Action

The biological function of Apoptosis Inducing siRNA centers on the post-transcriptional gene silencing of proteins that regulate cell survival. By eliminating the expression of genes associated with apoptosis inhibition—such as those responsible for mitochondrial integrity, caspase inhibition, or cell cycle progression—cells become sensitized to death signaling. The RNAi process is mediated by the RNA-induced silencing complex (RISC), which incorporates the antisense strand of the siRNA and guides it to the complementary target mRNA. Once bound, the mRNA is cleaved and degraded, resulting in a downstream apoptotic response that includes mitochondrial membrane depolarization, release of cytochrome c, and activation of executioner caspases.

Kit Composition and Technology

This product consists of 5 nanomoles of high-purity, duplexed siRNA, synthesized and quality-verified to ensure reproducibility and efficacy. The siRNA is optimized for use in mammalian cells and can be delivered using electroporation or lipid-based transfection methods. The formulation is free of endotoxins and suitable for use in serum-containing environments. Its molecular design allows for efficient uptake and gene silencing in a broad range of cell types. The siRNA does not require modification and is provided in a lyophilized format that is reconstituted in RNase-free water prior to use.

Applications and Experimental Use

Apoptosis Inducing siRNA is widely used in laboratory research as a functional control for confirming transfection efficiency and as a benchmark for validating apoptotic assays. It is particularly valuable in studies involving cancer biology, toxicology, or therapeutic gene silencing. Following transfection, apoptosis can be detected using caspase-3/7 activity assays, Annexin V binding, or mitochondrial potential assessments. Gene knockdown is typically measurable within 24–48 hours, while apoptotic markers may be observed between 48 and 72 hours post-transfection. It is recommended to include appropriate controls such as non-targeting siRNA to distinguish specific gene-silencing effects from non-specific toxicity.

Read More Information: Apoptosis Inducing siRNA

Request Quote here: https://altogen.com/request-quote/

siRNA Electroporation Buffer (30 ml)

Composition and Formulation

The buffer is formulated with low ionic strength and a neutral pH to reduce electrical conductivity and minimize the risk of arcing during electroporation. It contains osmoprotective agents such as sucrose or glycerol that help stabilize the cell membrane during and after pulse application. Buffering agents like phosphate or HEPES maintain physiological pH, while controlled levels of ions such as potassium and magnesium mimic intracellular conditions to support cell health. The solution is sterile, endotoxin-free, and free of RNases and DNases, ensuring compatibility with RNA-based delivery systems.

Mechanism of Action

Electroporation relies on brief electrical pulses to induce temporary pores in the plasma membrane, allowing siRNA molecules to enter the cytoplasm. The siRNA Electroporation Buffer facilitates this process by reducing the solution’s conductivity, thereby minimizing resistive heating and preserving cell viability. After pulse application, the buffer environment supports membrane resealing and intracellular recovery, helping cells return to a stable state while ensuring successful internalization of the siRNA payload.

Application Guidelines

Cells should be washed to remove culture medium and suspended in the electroporation buffer immediately prior to the procedure. The absence of serum and salts in the buffer ensures minimal interference with electric field delivery. Parameters such as voltage, capacitance, pulse duration, and cell density must be empirically optimized for each cell line. Following electroporation, cells should be transferred to pre-warmed growth medium containing serum or appropriate supplements to aid in recovery and support proliferation.

Performance and Benefits

Use of a properly formulated electroporation buffer significantly improves siRNA delivery while preserving high levels of cell viability. Researchers typically observe transfection efficiencies above 70% in well-optimized systems, including difficult-to-transfect cell types such as primary immune cells and stem cells. The low-conductivity formulation reduces the risk of cell damage caused by excessive current or heating during pulse delivery, resulting in consistent and reproducible transfection outcomes.

Read More Information: siRNA Electroporation Buffer (30 ml)

Request Quote here: https://altogen.com/request-quote/

Cell Cycle Arrest siRNA (5 nmol)

Mechanism of Action

This siRNA initiates post-transcriptional gene silencing by recruiting the RNA-induced silencing complex (RISC), which guides the antisense strand to complementary target mRNA. By targeting proteins such as Cyclin D1, CDK4, or CDC2, the siRNA prevents progression through critical checkpoints, resulting in cell cycle arrest. The downstream effects include decreased DNA synthesis, reduced phosphorylation of retinoblastoma protein, and accumulation of cells in either G1 or G2/M phase. Arrested cells may then undergo apoptosis or senescence depending on the experimental context.

Kit Composition and Technology

This product contains 5 nmol of high-purity, duplexed siRNA, synthesized and quality-validated to ensure reproducibility and target efficacy. The formulation is free of endotoxins and RNases, and it is provided in lyophilized form for long-term stability. The siRNA is suitable for delivery via lipid-based transfection reagents or electroporation, and is optimized for serum-compatible transfection of a wide variety of mammalian cell lines.

Applications and Experimental Use

Cell Cycle Arrest siRNA is ideal for validating transfection protocols and for experiments involving cell cycle analysis, scaffold development, drug testing, and pathway investigations. Following transfection, researchers can observe cell cycle distribution changes by flow cytometry using propidium iodide staining or BrdU incorporation assays. Protein-level confirmation may be achieved by measuring decreased levels of cyclins and CDKs, along with cell cycle inhibitors like p21 or p27. Effects on cell proliferation are typically evident within 24–72 hours post-transfection, with a visible accumulation of cells in the targeted phase.

Performance and Benefits

When used correctly, this siRNA consistently initiates cell cycle arrest in more than 70% of treated cells, depending on cell type and transfection method. It is a robust tool for validating transfection efficiency, optimizing assay sensitivity, and studying cell cycle-related biological processes. The reagent supports both short-term and longer-term experiments, depending on the stability of knockdown and cellular response.

Read More Information: Cell Cycle Arrest siRNA (5 nmol)

Request Quote here: https://altogen.com/request-quote/

Non-silencing control siRNA

Mechanism of Action

While the Non-silencing Control siRNA enters cells and engages the RNAi machinery, its sequence is carefully designed to avoid complementarity with any endogenous mRNA. It is incorporated into the RNA-induced silencing complex (RISC) like any functional siRNA, but since it does not bind to any target transcript, it results in no gene silencing. This makes it a critical internal control for distinguishing true biological effects of target-specific siRNAs from those caused by transfection, off-target interactions, or innate immune activation.

Composition and Formulation

The product consists of 5 nmol of high-quality, double-stranded siRNA supplied in lyophilized form. It is RNase- and endotoxin-free, ensuring compatibility with sensitive cell types and RNA-based assays. The siRNA duplex is synthesized with standard 21-mer design and includes 3′ dTdT overhangs for enhanced stability and uptake. It can be delivered using electroporation or lipid-based transfection methods and is suitable for use in both serum-free and serum-containing media.

Applications and Experimental Use

Non-silencing Control siRNA is used as a baseline control in gene silencing experiments across a wide range of mammalian cell lines. It is commonly included alongside gene-targeting siRNAs to assess the specificity of observed phenotypes. Researchers can compare gene expression levels, cell morphology, viability, and functional assays between non-silencing control–treated cells and those treated with gene-specific siRNAs. It is also used to optimize siRNA delivery conditions without the risk of interfering with cellular pathways.

Performance and Benefits

The Non-silencing Control siRNA offers high transfection efficiency without altering gene expression profiles or triggering apoptosis, stress signaling, or immune responses. It provides a reliable baseline for validating the specificity of target knockdown and ensures reproducibility in RNAi-based experiments. Its use is considered a best practice in any RNAi study, especially when phenotypic or functional changes are being analyzed.

Read More Information: Non-silencing control siRNA

Request Quote here: https://altogen.com/request-quote/